2019
DOI: 10.1016/j.radcr.2018.09.013
|View full text |Cite
|
Sign up to set email alerts
|

Primary perirenal angiosarcoma: A rare presentation of a perirenal mass

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 11 publications
0
2
0
Order By: Relevance
“…Angiosarcoma is a malignant vascular neoplasm which may occur in any location of the body, including the skin, soft tissue, breast, bone and visceral organs including the liver. Primary renal angiosarcoma is very rare, with about 70 cases described in the literature to date [49][50][51][52][53][54][55][56][57]. Most of these cases are seen in older men, with a peak incidence in the sixth to seventh decades and a pronounced male predilection (male-to-female ratio of 7:1) [49].…”
Section: Angiosarcomamentioning
confidence: 99%
See 1 more Smart Citation
“…Angiosarcoma is a malignant vascular neoplasm which may occur in any location of the body, including the skin, soft tissue, breast, bone and visceral organs including the liver. Primary renal angiosarcoma is very rare, with about 70 cases described in the literature to date [49][50][51][52][53][54][55][56][57]. Most of these cases are seen in older men, with a peak incidence in the sixth to seventh decades and a pronounced male predilection (male-to-female ratio of 7:1) [49].…”
Section: Angiosarcomamentioning
confidence: 99%
“…The management of renal angiosarcoma is controversial and not wellestablished; most patients were treated with radical nephrectomy followed by varying combinations of radiation and chemotherapy [51]. One recent study describes a case treated with neoadjuvant chemoradiation with excellent response, demonstrating potential for this therapeutic approach in future cases [56]. While targeted treatment with anti-angiogenic factors has been utilized with some success in non-renal angiosarcomas, two cases of renal angiosarcoma treated with recombinant interleukin-2 and bevacizumab ultimately resulted in death from disease [49,58].…”
Section: Angiosarcomamentioning
confidence: 99%